Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PHD finger protein 2 pseudogene 2 (PHF2P2) is a human pseudogene annotated in genomic databases but not translated into a functional protein product. Pseudogenes like PHF2P2 are genomic sequences that resemble known genes but have lost their ability to code for proteins due to mutations or truncations. There is no evidence that PHF2P2 produces a protein or plays a role in disease or cellular processes in humans. The designation "pseudogene" indicates it is not a canonical drug, receptor, or enzyme target and, based on current knowledge, is not considered for therapeutic intervention. PHF2P2 does not fit the typical criteria for a druggable target, and no functional protein product or pathway involvement is validated in the literature or major biological databases. There is a separate pseudogene (Phf8-ps) in the mouse genome for a related gene (PHF8), which has some residual function, but this does not apply to human PHF2P2. PHF2P2 is a pseudogene, not a canonical target or therapeutic protein in humans; no drugs, mechanisms, or disease roles are attributed to it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PHD finger protein 2 pseudogene 2 (PHF2P2).